Equillium Stock Analysis

EQ -  USA Stock  

USD 5.81  0.04  0.68%

The recent decline in stock price could raise concerns from insiders as the firm it trading at a share price of 5.81 on 37,578 in volume. The company directors and management have failed to build on market volatilities in May. However, diversifying your overall positions with Equillium may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.91. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Equillium partners.
Continue to Investing Opportunities.

Search Stock Analysis 

 
Refresh
The Equillium stock analysis report makes it easy to digest most publicly released information about Equillium and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Equillium stock analysis module also helps to analyze the Equillium price relationship with some important fundamental indicators such as market cap and management efficiency.

Equillium Stock Analysis Notes

About 53.0% of the company shares are held by company insiders. The book value of Equillium was currently reported as 2.82. The company recorded a loss per share of 1.47. Equillium had not issued any dividends in recent years. Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California. Equillium operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 31 people. To learn more about Equillium call Daniel Bradbury at 858 412 5302 or check out http://equilliumbio.com.

Equillium Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Equillium's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Equillium or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Equillium generates negative expected return over the last 90 days
Equillium has high historical volatility and very poor performance
Equillium is unlikely to experience financial distress in the next 2 years
Annual Net Loss to common stockholders was (29.81 M).
Equillium reports about 82.16 M in cash with (24.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.83.
Equillium has a frail financial position based on the latest SEC disclosures
Roughly 53.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Acquisition by Rothman Joel of 7742 shares of Equillium subject to Rule 16b-3

Equillium Upcoming and Recent Events

Earnings reports are used by Equillium to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Equillium previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report11th of August 2021
Next Earnings Report9th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End23rd of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Equillium Largest EPS Surprises

Earnings surprises can significantly impact Equillium's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-03-24
2020-12-31-0.39-0.350.0410 
2019-05-13
2019-03-31-0.3-0.34-0.0413 
2019-03-27
2018-12-31-0.2867-0.33-0.043315 
View All Earnings Estimates

Equillium SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Equillium prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Equillium investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Equillium specific information freely available to individual and institutional investors to make a timely investment decision.
11th of June 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
10th of June 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
7th of June 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
28th of May 2021
Submission of Matters to a Vote of Security Holders
View
13th of May 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
30th of March 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
24th of March 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
15th of March 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View

Equillium Thematic Classifications

In addition to having Equillium stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products IdeaPharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Equillium Market Capitalization

The company currently falls under 'Small-Cap' category with market capitalization of 178.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Equillium's market, we take the total number of its shares issued and multiply it by Equillium's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Equillium Profitablity

Equillium's profitability indicators refer to fundamental financial ratios that showcase Equillium's ability to generate income relative to its revenue or operating costs. If, let's say, Equillium is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Equillium's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Equillium's profitability requires more research than a typical breakdown of Equillium's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(0.44) (0.47) 
Return on Average Equity(0.55) (0.60) 
Return on Invested Capital(0.66) (0.71) 

Management Efficiency

The entity has Return on Asset (ROA) of (26.2) % which means that for every 100 dollars spent on asset, it generated loss of $26.2. This is way below average. Likewise, it shows return on total equity (ROE) of (53.38) %, which implies that it produced no returns to current stockholders. Equillium management efficiency ratios could be used to measure how well equillium manages its routine affairs as well as how well it operates its assets and liabilities. As of 17th of June 2021, Return on Average Assets is likely to drop to -0.47. In addition to that, Return on Average Equity is likely to drop to -0.6. As of 17th of June 2021, Total Liabilities is likely to drop to about 14.3 M. In addition to that, Current Liabilities is likely to drop to about 6.4 M
Last ReportedProjected for 2021
Book Value per Share 3.43  3.37 
Enterprise Value over EBIT(3.00) (3.24) 
Enterprise Value over EBITDA(3.24) (3.50) 
Price to Book Value 1.89  1.77 
Tangible Assets Book Value per Share 4.20  4.02 
Enterprise Value92.9 M88.5 M
Tangible Asset Value85.4 M85.1 M

Technical Drivers

As of the 17th of June 2021, Equillium shows the mean deviation of 3.65, and Coefficient Of Variation of (1,745). Equillium technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and collect data for nineteen technical drivers for Equillium, which can be compared to its rivals. Please confirm Equillium information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Equillium is priced favorably, providing market reflects its regular price of 5.81 per share. Given that Equillium has jensen alpha of (0.39), we urge you to verify Equillium's prevailing market performance to make sure the company can sustain itself at a future point.

Equillium Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Equillium more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Equillium Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Equillium insiders, such as employees or executives, is commonly permitted as long as it does not rely on Equillium's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Equillium insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Equillium Predictive Daily Indicators

Equillium intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Equillium stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Equillium Forecast Models

Equillium time-series forecasting models is one of many Equillium's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Equillium's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Equillium Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Equillium stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Equillium shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Equillium. By using and applying Equillium Stock analysis, traders can create a robust methodology for identifying Equillium entry and exit points for their positions.
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California. Equillium operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 31 people.

Current Equillium Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Equillium analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Equillium analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
13.5Strong Buy4Odds
Equillium current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Equillium analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Equillium stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Equillium, talking to its executives and customers, or listening to Equillium conference calls.
Equillium Analyst Advice Details

Equillium Stock Analysis Indicators

Equillium stock analysis indicators help investors evaluate how Equillium stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Equillium shares will generate the highest return on investment. By understating and applying Equillium stock analysis, traders can identify Equillium position entry and exit signals to maximize returns.
Quick Ratio11.34
Fifty Two Week Low2.53
Shares Short Prior Month1.28M
Average Daily Volume Last 10 Day213.78k
Average Daily Volume In Three Month167.84k
Shares Percent Shares Out3.23%
Short Percent Of Float5.94%
Forward Price Earnings-3.93
Float Shares17.98M
Fifty Two Week High27.05
Enterprise Value To Ebitda-3.46
Fifty Day Average6.31
Two Hundred Day Average6.47
Continue to Investing Opportunities. Note that the Equillium information on this page should be used as a complementary analysis to other Equillium's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Equillium Stock analysis

When running Equillium stock analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's stock examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Equity Search
Search for activelly-traded equities including funds and ETFs from over 30 global markets
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium stock's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Equillium value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.